Search - tctmd.com

Displaying 21 - 40 of 157

Sort: Relevancy | Date

News Daily News

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Shelley Wood

July 20, 2016

News Daily News

La Intervención de Sustitución Mínimamente Invasiva de las Cuerdas de la Válvula Mitral es Prometedora pero está en su Infancia

Shelley Wood

July 20, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Daily News

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

Michael O'Riordan

June 23, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Industry News

Gore Launches New 7.5 cm Length GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface

February 29, 2016

News Daily News

Procedural Techniques May Boost Aortic Remodeling After TEVAR, but Only for Acute Dissections

L.A. McKeown

January 24, 2016

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Features

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Yael L. Maxwell

November 01, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Daily News

在医疗保险人口中，EVAR的早期生存优势在3年后失去

July 23, 2015

News Daily News

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

July 23, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

News Daily News

一项研究调查了采用Lariat装置施行LAA封堵的并发症

May 05, 2015

Advertisement

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

La Intervención de Sustitución Mínimamente Invasiva de las Cuerdas de la Válvula Mitral es Prometedora pero está en su Infancia

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Gore Launches New 7.5 cm Length GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface

Procedural Techniques May Boost Aortic Remodeling After TEVAR, but Only for Acute Dissections

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

在医疗保险人口中，EVAR的早期生存优势在3年后失去

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

一项研究调查了采用Lariat装置施行LAA封堵的并发症

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content